LAPATINIB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 233 adverse event reports in the FDA FAERS database where LAPATINIB was used for Product used for unknown indication.
Most Reported Side Effects for LAPATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 382 | 19.3% | 35 | 131 |
| Disease progression | 227 | 11.5% | 37 | 21 |
| Palmar-plantar erythrodysaesthesia syndrome | 182 | 9.2% | 18 | 24 |
| Malignant neoplasm progression | 173 | 8.7% | 41 | 21 |
| Nausea | 161 | 8.1% | 17 | 67 |
| Metastases to central nervous system | 160 | 8.1% | 32 | 32 |
| Neutropenia | 160 | 8.1% | 11 | 27 |
| Vomiting | 155 | 7.8% | 16 | 67 |
| Asthenia | 148 | 7.5% | 19 | 38 |
| Fatigue | 139 | 7.0% | 13 | 50 |
| Off label use | 118 | 6.0% | 12 | 42 |
| Rash | 108 | 5.5% | 8 | 18 |
| Thrombocytopenia | 102 | 5.1% | 8 | 20 |
| Metastases to lymph nodes | 95 | 4.8% | 3 | 29 |
| Metastases to lung | 92 | 4.6% | 8 | 10 |
Other Indications for LAPATINIB
Breast cancer (447)
Breast cancer metastatic (434)
Her2 positive breast cancer (241)
Her-2 positive breast cancer (151)
Invasive ductal breast carcinoma (113)
Breast cancer female (37)
Neoplasm malignant (33)
Metastases to central nervous system (30)
Colorectal cancer metastatic (25)
Breast neoplasm (24)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)